Lacidipine-13C8 | MedChemExpress (MCE)
Lacidipine-13C8 is the deuterium labeled Lacidipine[1]. Lacidipine is an orally active and highly selective L-type calcium channel blocker that acts on smooth muscle calcium channels, primarily dilates peripheral arteries, reduces peripheral resistance, and has long-lasting anti-hypertensive activity. Lacidipine protects HKCs from apoptosis induced by ATP depletion and recovery by modulating the caspase-3 pathway. Lacidipine can be used in studies of hypertension, atherosclerosis and acute kidney injury (AKI)[2][3].
Trivial name | Lacidipine-13C8 |
Catalog Number | HY-B0347S1 |
Research Area | Cardiovascular Disease |
CAS# | 1261432-01-2 |
Purity | ≥98.00% |
SMILES | CCO[13C]([13C]1=[13C](N[13C]([13CH3])=[13C](C1C2=C(/C=C/C(OC(C)(C)C)=O)C=CC=C2)[13C](OCC)=O)[13CH3])=O |
PubChem Chemical Structure ID | 49849757 |
Size | 1 mg |
Supplier Page | https://www.medchemexpress.com/lacidipine-13c8.html |